Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: The aim of this study was to propose a localization strategy for bleeding sites in hemoptysis patients using their chest computed tomography (CT) findings.
Methods: Between January 2005 and July 2009, the chest CT findings of 161 hemoptysis patients were retrospectively reviewed. Following chest CT, the lobe with the most prominent ground glass attenuation (GGA) or specific lesions with the potential to cause pulmonary hemorrhage were analysed to develop a localization strategy for bleeding sites. Fibre optic bronchoscopy (FOB) findings of active bleeding were used as the standard reference for the bleeding sites.
Results: The concordance rate between the most prominent GGA and FOB findings was higher than that between specific lesions and FOB findings (Kappa value [k] = 0.751 vs. 0.448, p < 0.001). Among the specific lesions, there were high concordance rates between lung cancer and FOB findings (3/3, 100%) and fungus balls and FOB findings (8/9, 89%). The agreement of localization of the bleeding site between FOB findings and the localization strategy based on chest CT findings including the most prominent GGA, lung cancer and fungus balls, showed almost perfect (k = 0.904).
Conclusions: The localization of bleeding sites in hemoptysis patients could be determined by chest CT findings such as the most prominent GGA, malignancy and fungus ball.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123413 | PMC |
| http://dx.doi.org/10.1186/s12890-016-0322-1 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Axonal degeneration in hemorrhagic stroke: a systematic review.
Pharmacol Res
September 2025
University of Vienna, Department of Pharmaceutical Sciences, Division of Pharmacology and Toxicology, Vienna, Austria. Electronic address:
Hemorrhagic stroke occurs due to a rupture of a blood vessel in the brain. This leads to initial mechanical damage at the site of injury and secondary injuries including axonal degeneration (AxD). Since axons are critical for all brain functions, we systematically reviewed studies that focused on axonal degeneration in two major types of hemorrhagic stroke, intracerebral hemorrhage and subarachnoid hemorrhage, to understand how and to what extent AxD develops and to interrogate underlying mechanisms and potential therapeutic targets.
View Article and Find Full Text PDFMulticenter Study of Factors Associated with Visual and Anatomic Outcomes of Suprachoroidal Hemorrhage.
Retina
September 2025
Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA.
Purpose: To report outcomes of suprachoroidal hemorrhage (SCH).
Methods: Retrospective non-randomized study of eyes with SCH from two sites (1/1/2013-12/31/2022). The primary outcome was the 6-month change in visual acuity (VA).
Control of Port Site Bleeding With Liberal Use of Catheter Balloon Tamponade in Robotic Mitral Valve Surgery.
Innovations (Phila)
September 2025
Section of Cardiac Surgery, Department of Surgery, University of Chicago, IL, USA.
Objective: Port sites are a common source of perioperative bleeding in robotic cardiac surgery, which can be exacerbated by patient anatomy and anticoagulation. We present results from the liberal usage of a balloon-tipped coudé catheter for tamponade of robotic port sites during robotic mitral surgery.
Methods: All patients who underwent robotic mitral valve surgery at our institution from August 2016 to July 2022 were studied ( = 320).
An Innovative, Non-surgical, and Minimally Invasive Treatment for Peri-Implantitis: A Case Report.
Cureus
August 2025
Laser Laboratory, Oral Surgery Department, Wroclaw Medical University, Wroclaw, POL.
Peri-implantitis (PI) is a progressive inflammatory condition characterized by the destruction of peri-implant tissues and alveolar bone loss around dental implants. Despite its rising prevalence, there are still no effective treatment protocols for the condition. This case report presents a relatively novel non-surgical approach for managing PI.
View Article and Find Full Text PDFStrategies for Optimal Use of Biological Therapies in Managing Psoriasis: Focus on Secukinumab.
Dermatol Ther (Heidelb)
September 2025
Dermatology Clinic, University Hospital Company Polyclinic "G. Rodolico, San Marco", Catania, Italy.
Introduction: Psoriasis (PsO) is a common inflammatory dermatological condition with a substantial negative impact on patient quality of life. Several biological agents are available for the treatment of PsO, and clinicians and patients must consider various factors when deciding on the most appropriate biological agent.
Methods: Here, we report a set of consensus statements developed by an Italian PsO advisory board on use of the anti-interleukin-17A biological secukinumab in routine clinical practice.